Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients.

Keup C, Mach P, Aktas B, Tewes M, Kolberg HC, Hauch S, Sprenger-Haussels M, Kimmig R, Kasimir-Bauer S.

Clin Chem. 2018 May 16. pii: clinchem.2017.283531. doi: 10.1373/clinchem.2017.283531. [Epub ahead of print]

PMID:
29769179
2.

Predictors of outpatients' request for palliative care service at a medical oncology clinic of a German comprehensive cancer center.

Tewes M, Rettler T, Wolf N, Hense J, Schuler M, Teufel M, Beckmann M.

Support Care Cancer. 2018 May 5. doi: 10.1007/s00520-018-4245-7. [Epub ahead of print]

PMID:
29730713
3.

Quantitative HAADF STEM of SiGe in presence of amorphous surface layers from FIB preparation.

Grieb T, Tewes M, Schowalter M, Müller-Caspary K, Krause FF, Mehrtens T, Hartmann JM, Rosenauer A.

Ultramicroscopy. 2018 Jan;184(Pt B):29-36. doi: 10.1016/j.ultramic.2017.09.012. Epub 2017 Oct 13.

PMID:
29078105
4.

Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic Breast Cancer.

Bredemeier M, Edimiris P, Mach P, Kubista M, Sjöback R, Rohlova E, Kolostova K, Hauch S, Aktas B, Tewes M, Kimmig R, Kasimir-Bauer S.

Clin Chem. 2017 Oct;63(10):1585-1593. doi: 10.1373/clinchem.2016.269605. Epub 2017 Aug 3.

PMID:
28778937
5.

Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters.

Tewes M, Peis MW, Bogner S, Theysohn JM, Reinboldt MP, Schuler M, Welt A.

J Cancer Res Clin Oncol. 2017 Oct;143(10):2131-2141. doi: 10.1007/s00432-017-2462-y. Epub 2017 Jun 23.

PMID:
28646261
6.

Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.

Bredemeier M, Kasimir-Bauer S, Kolberg HC, Herold T, Synoracki S, Hauch S, Edimiris P, Bankfalvi A, Tewes M, Kimmig R, Aktas B.

Mol Med Rep. 2017 May;15(5):2957-2968. doi: 10.3892/mmr.2017.6415. Epub 2017 Mar 30.

7.

Regaining familiarity with own body after treatment for operable lung cancer - a qualitative longitudinal exploration.

Missel M, Pedersen JH, Hendriksen C, Tewes M, Adamsen L.

Eur J Cancer Care (Engl). 2016 Nov;25(6):1076-1090. doi: 10.1111/ecc.12383. Epub 2015 Sep 10.

PMID:
26361265
8.

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.

Aktas B, Kasimir-Bauer S, Müller V, Janni W, Fehm T, Wallwiener D, Pantel K, Tewes M; DETECT Study Group.

BMC Cancer. 2016 Jul 25;16:522. doi: 10.1186/s12885-016-2587-4.

9.

Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.

Bredemeier M, Edimiris P, Tewes M, Mach P, Aktas B, Schellbach D, Wagner J, Kimmig R, Kasimir-Bauer S.

Oncotarget. 2016 Jul 5;7(27):41677-41690. doi: 10.18632/oncotarget.9528.

10.

Use of prestudy heparin did not influence the efficacy and safety of rivaroxaban in patients treated for symptomatic venous thromboem-bolism in the EINSTEIN DVT and EINSTEIN PE studies.

Prandoni P, Prins MH, Cohen AT, Müller K, Pap ÁF, Tewes MC, Lensing AW.

Acad Emerg Med. 2015 Feb;22(2):142-9. doi: 10.1111/acem.12585. Epub 2015 Feb 9.

11.

Exercise intervention for patients diagnosed with operable non-small cell lung cancer: a qualitative longitudinal feasibility study.

Missel M, Pedersen JH, Hendriksen C, Tewes M, Adamsen L.

Support Care Cancer. 2015 Aug;23(8):2311-8. doi: 10.1007/s00520-014-2579-3. Epub 2015 Jan 11.

PMID:
25577502
12.

Perioperative nursing in public university hospitals: an ethnography.

Sørensen EE, Olsen IØ, Tewes M, Uhrenfeldt L.

BMC Nurs. 2014 Dec 9;13(1):45. doi: 10.1186/s12912-014-0045-7. eCollection 2014.

13.

Diagnosis as the First Critical Point in the Treatment Trajectory: An Exploration of Operable Lung Cancer Patients' Lived Experiences.

Missel M, Pedersen JH, Hendriksen C, Tewes M, Adamsen L.

Cancer Nurs. 2015 Nov-Dec;38(6):E12-21. doi: 10.1097/NCC.0000000000000209.

PMID:
25275581
14.

Annual cross-sectional study of nurse-sensitive problems: how to keep a finger on the pulse.

Færch J, Tewes M, Overgaard D, Christensen RF, Moons P.

J Nurs Care Qual. 2015 Jul-Sep;30(3):E10-6. doi: 10.1097/NCQ.0000000000000082.

PMID:
25259767
15.
16.

Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer.

Tewes M, Kasimir-Bauer S, Welt A, Schuler M, Kimmig R, Aktas B.

J Cancer Res Clin Oncol. 2015 Jan;141(1):87-92. doi: 10.1007/s00432-014-1784-2. Epub 2014 Aug 10.

PMID:
25108406
17.

Loss of genetic diversity among ocelots in the United States during the 20th century linked to human induced population reductions.

Janecka JE, Tewes ME, Laack L, Caso A, Grassman LI, Honeycutt RL.

PLoS One. 2014 Feb 26;9(2):e89384. doi: 10.1371/journal.pone.0089384. eCollection 2014.

18.

Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients.

Welt A, Tewes M, Aktas B, O Hoffmann O, Wiesweg M, Ting S, Reis H, Worm K, Richly H, Hense J, Palmer MR, Lee BH, Wendling J, Kossow J, Scheulen ME, Lehnerdt C, Kohl M, Derks C, Skottky S, Haus U, Schmid KW, Kimmig R, Schuler M, Kasper S.

Breast Cancer Res Treat. 2013 Nov;142(1):81-8.

PMID:
24122392
19.

Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center.

Wiesweg M, Ting S, Reis H, Worm K, Kasper S, Tewes M, Welt A, Richly H, Meiler J, Bauer S, Hense J, Gauler TC, Köhler J, Eberhardt WE, Darwiche K, Freitag L, Stamatis G, Breitenbücher F, Wohlschlaeger J, Theegarten D, Derks C, Cortes-Incio D, Linden G, Skottky S, Lütkes P, Dechêne A, Paul A, Markus P, Schmid KW, Schuler M.

Eur J Cancer. 2013 Oct;49(15):3076-82. doi: 10.1016/j.ejca.2013.06.014. Epub 2013 Jul 19.

PMID:
23876834
20.

Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.

Aktas B, Kasimir-Bauer S, Lehmann N, Kimmig R, Tewes M.

Oncol Rep. 2013 Jul;30(1):441-7. doi: 10.3892/or.2013.2409. Epub 2013 Apr 22.

PMID:
23604361
21.

Demographic history of an elusive carnivore: using museums to inform management.

Holbrook JD, Deyoung RW, Tewes ME, Young JH.

Evol Appl. 2012 Sep;5(6):619-28. doi: 10.1111/j.1752-4571.2012.00241.x. Epub 2012 Feb 7.

22.

Implementing nutritional guidelines -- the effect of systematic training for nurse nutrition practitioners.

Pedersen PU, Tewes M, Bjerrum M.

Scand J Caring Sci. 2012 Mar;26(1):178-85. doi: 10.1111/j.1471-6712.2011.00912.x. Epub 2011 Sep 2.

PMID:
21883340
23.

Nurses' self-reported knowledge about and attitude to nutrition -- before and after a training programme.

Bjerrum M, Tewes M, Pedersen P.

Scand J Caring Sci. 2012 Mar;26(1):81-9. doi: 10.1111/j.1471-6712.2011.00906.x. Epub 2011 Jul 1.

PMID:
21718341
24.

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

Aktas B, Müller V, Tewes M, Zeitz J, Kasimir-Bauer S, Loehberg CR, Rack B, Schneeweiss A, Fehm T.

Gynecol Oncol. 2011 Aug;122(2):356-60. doi: 10.1016/j.ygyno.2011.04.039. Epub 2011 May 24.

PMID:
21605893
25.

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res. 2009;11(4):R46. doi: 10.1186/bcr2333. Epub 2009 Jul 9.

26.

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.

Tewes M, Aktas B, Welt A, Mueller S, Hauch S, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res Treat. 2009 Jun;115(3):581-90. doi: 10.1007/s10549-008-0143-x. Epub 2008 Aug 5.

PMID:
18679793
27.

Comparison of antibody and aptamer receptors for the specific detection of thrombin with a nanometer gap-sized impedance biosensor.

Schlecht U, Malavé A, Gronewold T, Tewes M, Löhndorf M.

Anal Chim Acta. 2006 Jul 28;573-574:65-8. Epub 2006 Feb 17.

PMID:
17723506
28.

Detection of Rev peptides with impedance-sensors--comparison of device-geometries.

Schlecht U, Malavé A, Gronewold TM, Tewes M, Löhndorf M.

Biosens Bioelectron. 2007 Apr 15;22(9-10):2337-40. Epub 2006 Aug 9.

PMID:
16901685
29.

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

Strumberg D, Richly H, Hilger RA, Schleucher N, Korfee S, Tewes M, Faghih M, Brendel E, Voliotis D, Haase CG, Schwartz B, Awada A, Voigtmann R, Scheulen ME, Seeber S.

J Clin Oncol. 2005 Feb 10;23(5):965-72. Epub 2004 Dec 21.

PMID:
15613696
30.

Novel interaction partners of the TPR/MET tyrosine kinase.

Schaaf CP, Benzing J, Schmitt T, Erz DH, Tewes M, Bartram CR, Janssen JW.

FASEB J. 2005 Feb;19(2):267-9. Epub 2004 Nov 16.

PMID:
15546961
31.

Comparative immobilization of wild felids in Thailand.

Grassman LI Jr, Austin SC, Tewes ME, Silvy NJ.

J Wildl Dis. 2004 Jul;40(3):575-8.

PMID:
15465729
32.

A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors.

Mross K, Richly H, Schleucher N, Korfee S, Tewes M, Scheulen ME, Seeber S, Beinert T, Schweigert M, Sauer U, Unger C, Behringer D, Brendel E, Haase CG, Voliotis D, Strumberg D.

Ann Oncol. 2004 Aug;15(8):1284-94.

PMID:
15277271
33.

Ticks (Acari: Ixodidae) parasitizing wild carnivores in Phu Khieo Wildlife Sanctuary, Thailand.

Grassman LI Jr, Sarataphan N, Tewes ME, Silvy NJ, Nakanakrat T.

J Parasitol. 2004 Jun;90(3):657-9.

PMID:
15270119
34.

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.

Vanhoefer U, Tewes M, Rojo F, Dirsch O, Schleucher N, Rosen O, Tillner J, Kovar A, Braun AH, Trarbach T, Seeber S, Harstrick A, Baselga J.

J Clin Oncol. 2004 Jan 1;22(1):175-84.

PMID:
14701780
35.

Helminths of the ocelot from southern Texas.

Pence DB, Tewes ME, Laack LL.

J Wildl Dis. 2003 Jul;39(3):683-9.

PMID:
14567231
36.

Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study.

Tewes M, Schleucher N, Achterrath W, Wilke HJ, Frings S, Seeber S, Harstrick A, Rustum YM, Vanhoefer U.

Ann Oncol. 2003 Sep;14(9):1442-8.

PMID:
12954586
37.

Modified pressure distribution patterns in walking following reduction of plantar sensation.

Eils E, Nolte S, Tewes M, Thorwesten L, Völker K, Rosenbaum D.

J Biomech. 2002 Oct;35(10):1307-13.

PMID:
12231276
38.
39.

Immobilization of wild ocelots with tiletamine and zolazepam in southern Texas.

Shindle DB, Tewes ME.

J Wildl Dis. 2000 Jul;36(3):546-50.

PMID:
10941742
40.

[Nursing records improving].

Thoms M, Brems K, Tewes M, De Lichtenberg AM.

Sygeplejersken. 1998 Jan 23;98(4):20-5. Danish. No abstract available.

PMID:
9496145
41.

Notoedric mange in an ocelot (Felis pardalis) from southern Texas.

Pence DB, Tewes ME, Shindle DB, Dunn DM.

J Wildl Dis. 1995 Oct;31(4):558-61.

PMID:
8592392
42.
43.

Seroepidemiological study of Taenia saginata cysticercosis in Swaziland.

Hughes G, Hoque M, Tewes MS, Wright SH, Harrison LJ.

Res Vet Sci. 1993 Nov;55(3):287-91.

PMID:
8284490
44.
45.

[Factors influencing the corrosion of amalgams].

Meyer G, Tewes M, Wiesner A, Nägerl H.

Dtsch Zahnarztl Z. 1989 Jul;44(7):544-7. German.

PMID:
2630286
46.

Leprosy in wild armadillos (Dasypus novemcinctus) of the Texas Gulf Coast: epidemiology and mycobacteriology.

Smith JH, Folse DS, Long EG, Christie JD, Crouse DT, Tewes ME, Gatson AM, Ehrhardt RL, File SK, Kelly MT.

J Reticuloendothel Soc. 1983 Aug;34(2):75-88.

PMID:
6350581
47.

[Nursing research. We must argue for nursing and use of resources].

Tewes M.

Sygeplejersken. 1983 Feb 16;83(7):4-7. Danish. No abstract available.

PMID:
6552098
48.

[Development of health and nursing care in an ambulatory clinic].

Tewes M.

Sygeplejersken. 1982 Jul 28;82(29):4-7. Danish. No abstract available.

PMID:
6923614
49.

[Self catheterization - an aid to patients who cannot empty the bladder with normal urination].

Tewes M, Maegaard E.

Sygeplejersken. 1982 Jun 23;82(24):6-7. Danish. No abstract available.

PMID:
6920928

Supplemental Content

Support Center